Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Improper storage of Insulin injections worth Rs 5 lakhs: DCA raids medical distributor

Ruchika Sharma22 Jan 2024 12:30 PM IST

Hyderabad: Officials from the Drugs Control Administration (DCA), Telangana, conducted a raid on the premises of a medical distributor in Kapra,...

Bayer gets UK nod for Lynkuet for moderate to severe vasomotor symptoms associated with menopause

Bayer holds off on break up to focus on internal reorganisation for now: Sources

Ruchika Sharma22 Jan 2024 11:30 AM IST

Bayer AG will likely hold off on presenting break-up plans at an investor update scheduled for early March as CEO Bill Anderson prefers to focus...

Former Pfizer employee convicted of insider trading on COVID drug Paxlovid trial

Ruchika Sharma22 Jan 2024 10:11 AM IST

A former employee of Pfizer Inc was convicted of insider trading on Thursday for buying stock options in November 2021 just before Pfizer announced...

Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag International

JnJ Balversa gets full USFDA nod to treat locally advanced or metastatic Bladder Cancer with Select Genetic Alterations

Ruchika Sharma21 Jan 2024 4:30 PM IST

Raritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application...

Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion deal

USFDA finds new manufacturing lapses at Eli Lilly plant: Report

Ruchika Sharma21 Jan 2024 4:00 PM IST

U.S. inspectors recently uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by federal investigators, according...

Bayer Eylea 8 mg gets Japanese marketing nod

Ruchika Sharma21 Jan 2024 1:00 PM IST

Berlin: Bayer has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted market authorization for Eylea 8 mg...

AstraZeneca, Summit in discussions over USD 15 billion cancer drug licensing deal: Report

AstraZeneca Voydeya approved in Japan for paroxysmal nocturnal haemoglobinuria

Ruchika Sharma21 Jan 2024 12:30 PM IST

Cambridge: AstraZeneca has announced that Voydeya (danicopan) has been approved in Japan for the treatment of paroxysmal nocturnal...

Havisure: India's first indigenously developed Hepatitis A vaccine launched

Ruchika Sharma20 Jan 2024 2:23 PM IST

It is a two-dose vaccine wherein the first dose is administered at 12 months of age and the second dose is given at least 6 months after the first...

Shilpa Medicare gets Germany marketing authorization for Amifampridine Tablets

Ruchika Sharma20 Jan 2024 12:30 PM IST

Hyderabad: Shilpa Medicare Limited has received Marketing Authorization from Germany, EU for Amifampridine Tablets, 10 mg under the National...

Shilpa Medicare arm partners with Orion Corporation for Recombinant Human Albumin for European Market

Shilpa Medicare gets Code J for Pemetrexed Injection

Ruchika Sharma20 Jan 2024 12:30 PM IST

Shilpa's - NDA Pemetrexed Injection, is a novel ready-to-use injection which eliminates the need for reconstitution and dilution before administration...

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

Roche gets European Commission marketing nod for Tecentriq SC for multiple cancer types

Ruchika Sharma20 Jan 2024 11:24 AM IST

Basel: Roche has announced that the European Commission has granted marketing authorisation for Tecentriq SC (atezolizumab), the European Union (EU)'s...

Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license

Zydus, Synthon enter into licensing, supply agreement for Palbociclib Tablets for US market

Ruchika Sharma19 Jan 2024 3:30 PM IST

Ahmedabad: Zydus Lifesciences Ltd., a global healthcare company announced that its wholly owned subsidiary, Zydus Worldwide DMCC, has entered...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok